Home › Chronic Progressive Multiple Sclerosis › Georgia
Chronic Progressive Multiple Sclerosis clinical trials in Georgia
3 studies for Chronic Progressive Multiple Sclerosis are looking for participants at sites in Georgia.
A Study of Ocrelizumab Administered Subcutaneously in Participants With Multiple Sclerosis Who Switch From an Approved Anti-CD20 Therapy
- Atlanta Neuroscience Institute, Atlanta
RecruitingPhase 4
Ages 18 to 65 · All sexes · Updated Sep 30, 2026 · NCT07609719A Phase 2a Study of SUN-627 in Participants With Non-Active Secondary Progressive and Primary Progressive Multiple Sclerosis (SPMS/PPMS)
- Local Institution - Site 102, Atlanta
RecruitingPhase 2
Ages 18 to 70 · All sexes · Updated Sep 25, 2026 · NCT07840326A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
- Joi Life Wellness Group LLC, Smyrna
RecruitingPhase 3
Ages 18 to 65 · All sexes · Updated Jul 29, 2026 · NCT07225504From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.